Market Research Report
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia
|Published by||GlobalData||Product code||920915|
|Published||Content info||119 Pages
Delivery time: 1-2 business days
|CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia|
|Published: December 31, 2019||Content info: 119 Pages||
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Colombia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Colombia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.
The Colombian healthcare market has significant potential for growth. The extensive health insurance system and presence of Free Trade Agreement (FTA) with the US are the main drivers for growth. The pharmaceutical value for Colombia in 2011 was $2.66B and declined to $1.71B in 2016 at negative CAGR of 8.5%.The pharmaceutical market is expected to reach $1.45B in 2022. The medical devices market in Colombia is mainly import-based. Colombia offers affordable private healthcare with better quality.
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Colombia, and includes -
This report will enhance your decision-making capability by allowing you to -